The estimated Net Worth of Eric J Loumeau is at least $3.95 Milione dollars as of 16 February 2024. Mr. Loumeau owns over 5,000 units of AnaptysBio Inc stock worth over $293,344 and over the last 10 years he sold ANAB stock worth over $114,558. In addition, he makes $3,541,570 as Chief Operating Officer e General Counsel at AnaptysBio Inc.
Eric has made over 10 trades of the AnaptysBio Inc stock since 2017, according to the Form 4 filled with the SEC. Most recently he exercised 5,000 units of ANAB stock worth $70,100 on 16 February 2024.
The largest trade he's ever made was exercising 10,000 units of AnaptysBio Inc stock on 10 February 2021 worth over $140,200. On average, Eric trades about 1,486 units every 90 days since 2015. As of 16 February 2024 he still owns at least 8,240 units of AnaptysBio Inc stock.
You can see the complete history of Mr. Loumeau stock trades at the bottom of the page.
Eric Joseph Loumeau serves as Chief Operating Officer, General Counsel of the Company. Mr. Loumeau will lead business strategy, operations and legal affairs at AnaptysBio. He joined AnaptysBio in August 2018 as General Counsel and has also served as Interim Chief Financial Officer since August 2019. Prior to AnaptysBio, Mr. Loumeau has served as General Counsel and Chief Compliance Officer at Otonomy, Chief Financial Officer of Rempex Pharmaceutics and General Counsel at Hollis-Eden Pharmaceuticals. Mr. Loumeau has also practiced securities and corporate law at multiple national law firms. Mr. Loumeau received his J.D. from Boalt Hall School of Law at the University of California, Berkeley, and his B.S. in Finance from Brigham Young University.
As the Chief Operating Officer e General Counsel of AnaptysBio Inc, the total compensation of Eric Loumeau at AnaptysBio Inc is $3,541,570. There are 1 executives at AnaptysBio Inc getting paid more, with Hamza Suria having the highest compensation of $7,875,190.
Eric Loumeau is 57, he's been the Chief Operating Officer e General Counsel of AnaptysBio Inc since 2020. There are 7 older and 6 younger executives at AnaptysBio Inc. The oldest executive at AnaptysBio Inc is Hollings Renton, 73, who is the Lead Independent Director.
Eric's mailing address filed with the SEC is 4796 Executive Dr, San Diego, CA 92121, USA.
Over the last 8 years, insiders at AnaptysBio Inc have traded over $37,024,151 worth of AnaptysBio Inc stock and bought 5,919,575 units worth $115,520,117 . The most active insiders traders include Holdings A/S Novo, Capital, Llc Eco R1 e James N Topper. On average, AnaptysBio Inc executives and independent directors trade stock every 40 days with the average trade being worth of $4,143,306. The most recent stock trade was executed by Paul F. Lizzul on 14 August 2024, trading 2,000 units of ANAB stock currently worth $37,000.
founded in 2005, anaptysbio, inc. is a privately-held company focused on the generation of antibody therapeutics, and the leader in the use of somatic hypermutation (shm) for antibody discovery and optimization. anaptysbio is building a pipeline of novel therapeutic antibody product candidates, including differentiated programs in cancer immunotherapy, inflammation, muscle wasting disorders, fibrosis and antibody-drug conjugate applications. anaptysbio’s proprietary shm-xel platform, which couples fully human antibody libraries with in vitro somatic hypermutation (shm) in mammalian cells to generate high affinity lead candidates, replicates key features of the human immune system and overcomes limitations of prior antibody technologies. by harnessing the natural mechanism of antibody maturation under controlled conditions, shm-xel allows for the selection of optimal antibody properties such as high affinity, function, cross-reactivity, epitope diversity and manufacturability. the c
AnaptysBio Inc executives and other stock owners filed with the SEC include: